Evidence map›Paper›PMID 32132633›Full record

ArticleScientific reports2020

Very-long-chain fatty acid metabolic capacity of 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) promotes replication of hepatitis C virus and related flaviviruses.

Bassim Mohamed, Clément Mazeaud, Martin Baril, Donald Poirier, Aïssatou Aïcha Sow, Laurent Chatel-Chaix, Vladimir Titorenko, Daniel Lamarre

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Lipid Droplets and Their Participation in Zika Virus Infection.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Whole Lotta Lipids-from HCV RNA Replication to the Mature Viral Particle.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Bassim MohamedCentre de Recherche du CHUM (CRCHUM) et Faculté de Médecine, Université de Montréal, Montréal, Canada.
Clément MazeaudInstitut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Université du Québec, Laval, Canada.
Martin BarilCentre de Recherche du CHUM (CRCHUM) et Faculté de Médecine, Université de Montréal, Montréal, Canada.
Donald PoirierCentre de recherche du CHU de Québec et Faculté de médecine, Université Laval, Québec, Canada.
Aïssatou Aïcha SowInstitut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Université du Québec, Laval, Canada.
Laurent Chatel-ChaixInstitut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Université du Québec, Laval, Canada.
Vladimir TitorenkoConcordia University, Montréal, Canada.ORCID http://orcid.org/0000-0001-5819-7545
Daniel LamarreCentre de Recherche du CHUM (CRCHUM) et Faculté de Médecine, Université de Montréal, Montréal, Canada. daniel.lamarre@umontreal.ca.
Institut National de la Recherche Scientifique · CACentre Hospitalier de l’Université de Montréal · CAConcordia University · USCornell University · USNational Research Centre · EGUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flaviviridae infections represent a major global health burden. By deciphering mechanistic aspects of hepatitis C virus (HCV)-host interactions, one could discover common strategy for inhibiting the replication of related flaviviruses. By elucidating the HCV interactome, we identified the 17-beta-hydroxysteroid dehydrogenase type 12 (HSD17B12) as a human hub of the very-long-chain fatty acid (VLCFA) synthesis pathway and core interactor. Here we show that HSD17B12 knockdown (KD) impairs HCV replication and reduces virion production. Mechanistically, depletion of HSD17B12 induces alterations in VLCFA-containing lipid species and a drastic reduction of lipid droplets (LDs) that play a critical role in virus assembly. Oleic acid supplementation rescues viral RNA replication and production of infectious particles in HSD17B12 depleted cells, supporting a specific role of VLCFA in HCV life cycle. Furthermore, the small-molecule HSD17B12 inhibitor, INH-12, significantly reduces replication and infectious particle production of HCV as well as dengue virus and Zika virus revealing a conserved requirement across Flaviviridae virus family. Overall, the data provide a strong rationale for the advanced evaluation of HSD17B12 inhibition as a promising broad-spectrum antiviral strategy for the treatment of Flaviviridae infections.

Indexed as

17-Hydroxysteroid DehydrogenasesAnimalsChlorocebus aethiopsHeLa CellsHepacivirusHepatitis CHep G2 CellsHumansOleic AcidVero CellsVirus Replication17beta-hydroxysteroid dehydrogenase type 317-Hydroxysteroid DehydrogenasesOleic Acid

Identifiers

PMID32132633
PMCPMC7055353
OpenAlexW3010264450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.